| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Business Officer | COO &Cbo
1 company
Nash Huw M. is a Chief Business Officer at Stoke Therapeutics, Inc.. Recent SEC Form 4 filings include 0 buys and 9 sells.
Estimated insider holdings value: $1K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Aug 28, 2020 | STOK Stoke Therapeutics, Inc. | COO &Cbo | Sale+OE | 2,081 | $30.00 | $62,430.00 | -100% | |
| Aug 3, 2020 | STOK Stoke Therapeutics, Inc. | COO &Cbo | Sale+OE | 5,700 | $24.73 | $140,943.33 | -100% | |
| Jul 16, 2020 | STOK Stoke Therapeutics, Inc. | COO &Cbo | Sale+OE | 1,900 | $25.06 | $47,614.00 | -100% | |
| Jul 7, 2020 | STOK Stoke Therapeutics, Inc. | COO &Cbo | Sell | 913 | $22.41 | $20,456.86 | -100% | |
| Jul 1, 2020 | STOK Stoke Therapeutics, Inc. | COO &Cbo | Sale+OE | 3,800 | $23.15 | $87,967.72 | -100% | |
| Jun 1, 2020 | STOK Stoke Therapeutics, Inc. | COO &Cbo | Sale+OE | 2,107 | $27.18 | $57,263.26 | -80.8% | |
| Mar 2, 2020 | STOK Stoke Therapeutics, Inc. | COO &Cbo | Sale+OE | 49,143 | $25.89 | $1,272,549.14 | -75.4% |